Cytomegalovirus-induced interstitial pneumonitis in a patient with dermatomyositis

Clin Rheumatol. 2006 Sep;25(5):731-3. doi: 10.1007/s10067-005-0062-8. Epub 2005 Nov 3.

Abstract

Dermatomyositis (DM) patients might present with pulmonary involvement as the first manifestation or during the follow-up period. It is sometimes difficult to determine whether the clinical manifestations related with pulmonary involvement are due to DM or to an infectious process. We report a case of DM patient who developed interstitial pneumonitis induced by cytomegalovirus (CMV) while receiving immunosuppressive treatment. To the best of our knowledge, this is the second report in the literature of interstitial pneumonitis secondary to CMV infection in a patient with DM.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antiviral Agents / therapeutic use
  • Azathioprine / adverse effects
  • Cyclosporine / adverse effects
  • Cytomegalovirus / immunology
  • Cytomegalovirus / isolation & purification
  • Cytomegalovirus / pathogenicity*
  • Cytomegalovirus Infections / complications*
  • Cytomegalovirus Infections / drug therapy
  • Cytomegalovirus Infections / immunology
  • Dermatomyositis / complications*
  • Dermatomyositis / drug therapy
  • Dermatomyositis / immunology
  • Drug Therapy, Combination
  • Female
  • Humans
  • Immunocompromised Host
  • Immunosuppressive Agents / adverse effects
  • Lung Diseases, Interstitial / complications*
  • Lung Diseases, Interstitial / drug therapy
  • Lung Diseases, Interstitial / immunology
  • Opportunistic Infections / complications*
  • Opportunistic Infections / drug therapy
  • Opportunistic Infections / immunology
  • Pneumonia, Viral / complications*
  • Pneumonia, Viral / drug therapy
  • Pneumonia, Viral / immunology
  • Prednisolone / adverse effects
  • Radiography, Thoracic
  • Treatment Outcome

Substances

  • Antiviral Agents
  • Immunosuppressive Agents
  • Cyclosporine
  • Prednisolone
  • Azathioprine